NSE KIMS · BSE 543308 · Healthcare Facilities · NIFTY 500
Krishna Institute of Medical Sciences Ltd Share Price
₹798.30
▲ +₹3.89 · 0.49%
NSE · as of 24 Sep 2026, 9:51 AM · BSE ₹802.25
Today's range
₹796.50Low₹810.40High
52-week range
₹575.55Low · 27 Jan 2026₹858.15High · 6 Jul 2026
Krishna Institute of Medical Sciences Ltd Overview
Where the price stands, how it has moved and how it sits against its averages.
Krishna Institute of Medical Sciences Ltd shares last traded at ₹798.30 on the NSE, up 0.49% on the day. That is 7.0% below the 52-week high of ₹858.15 and 38.7% above the 52-week low of ₹575.55. The stock trades at 159.64× earnings, above the sector average of 30.42. Its market value is ₹33,646 Cr.
Price returns
1 Day▲ +0.49%
5 Days▲ +4.10%
This month▲ +5.63%
3 Months▲ +0.11%
6 Months▲ +22.89%
This year▲ +31.13%
1 Year▲ +8.37%
Against the market: 1 Month ▲ +9.28% · 3 Months ▲ +3.00% · 6 Months ▲ +23.62% · This year ▲ +49.34% · 1 Year ▲ +18.91%
Shading grows with the size of the move. Prices refresh every 15 minutes while the market is open (9:15 AM–3:30 PM IST); next update from Mon 28 Sep, 9:15 AM.
Moving averages — price is above 6 of 6
- Today's price₹798.30
- 5-day average₹789.40 ▲ price 1.1% above
- 50-day average₹788.21 ▲ price 1.3% above
- 100-day average₹780.54 ▲ price 2.3% above
- 10-day average₹778.17 ▲ price 2.6% above
- 20-day average₹770.69 ▲ price 3.6% above
- 300-day average₹751.85 ▲ price 6.2% above
Averages above today's price sit higher on the ladder. Price above most of its averages is usually read as an upward trend.
Krishna Institute of Medical Sciences Ltd Financial Results
Revenue and net profit in ₹ crore, with the full statements underneath.
3,905
385
241
Year by year
| Fiscal year | Revenue | Growth | Net profit | Net margin | EPS | Dividend |
|---|---|---|---|---|---|---|
| FY 2026 | ₹3,905 Cr | ▲ +28.6% | ₹241 Cr | 6.2% | ₹6.03 | — |
| FY 2025 | ₹3,035 Cr | ▲ +21.5% | ₹385 Cr | 12.7% | ₹9.61 | — |
| FY 2024 | ₹2,498 Cr | ▲ +13.7% | ₹310 Cr | 12.4% | ₹7.75 | — |
| FY 2023 | ₹2,198 Cr | ▲ +33.1% | ₹336 Cr | 15.3% | ₹8.41 | — |
| FY 2022 | ₹1,651 Cr | ▲ +24.1% | ₹333 Cr | 20.2% | ₹8.38 | — |
| FY 2021 | ₹1,330 Cr | ▲ +18.5% | ₹201 Cr | 15.1% | ₹5.03 | ₹0.00 |
| FY 2020 | ₹1,123 Cr | — | ₹119 Cr | 10.6% | ₹2.98 | ₹0.00 |
1,180
102
42
Quarter by quarter
| Quarter | Revenue | vs prev. qtr | Net profit | Net margin | EPS |
|---|---|---|---|---|---|
| Q1 FY27 | ₹1,180 Cr | ▲ +9.8% | ₹42 Cr | 3.5% | ₹1.04 |
| Q4 FY26 | ₹1,075 Cr | ▲ +7.7% | ₹43 Cr | 4.0% | ₹1.06 |
| Q3 FY26 | ₹998 Cr | ▲ +3.9% | ₹53 Cr | 5.4% | ₹1.33 |
| Q2 FY26 | ₹961 Cr | ▲ +10.2% | ₹67 Cr | 7.0% | ₹1.67 |
| Q1 FY26 | ₹872 Cr | ▲ +9.4% | ₹79 Cr | 9.0% | ₹1.97 |
| Q4 FY25 | ₹797 Cr | ▲ +3.2% | ₹102 Cr | 12.8% | ₹2.54 |
| Q3 FY25 | ₹772 Cr | — | ₹89 Cr | 11.5% | ₹2.22 |
Balance sheet — FY26
Owes (liabilities)Shareholders' equity
71%
29%
- Total assets₹7,759 Cr
- Total liabilities₹5,511 Cr
- Shareholders' equity₹2,247 Cr
- Total debt₹4,253 Cr
- Cash & investments₹71 Cr
- Current ratio0.76×
- Revenue growth, 5 yr24.04% a year
- EPS growth, 5 yr3.71% a year
- Operating margin (TTM)11.75%
- Net margin (TTM)4.61%
Cash flow — FY26
Operating activities
▲ ₹511 Cr
Investing activities
▼ −₹1,452 Cr
Financing activities
▲ ₹940 Cr
Free cash flow
▼ −₹917 Cr
Net change in cash
▼ −₹1 Cr
Right of the line = cash coming in, left = cash going out. Free cash flow = cash from operations minus capital spending.
Full financial statements, FY20–FY26
| ₹ crore | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|
| Total revenue | 1,122.65 | 1,329.94 | 1,650.83 | 2,197.68 | 2,498.14 | 3,035.10 | 3,904.60 |
| Cost of revenue | 543.00 | 595.31 | 703.77 | 1,022.52 | 1,157.87 | 1,396.80 | 1,935.10 |
| Gross profit | 579.64 | 734.63 | 947.06 | 1,175.16 | 1,340.28 | 1,638.30 | 1,969.50 |
| Operating expenses | 946.22 | 1,026.80 | 1,203.68 | 1,721.46 | 2,003.79 | 2,428.20 | 3,391.10 |
| Operating income | 176.42 | 303.14 | 447.14 | 476.22 | 494.35 | 606.90 | 513.50 |
| Depreciation | 70.61 | 69.54 | 72.67 | 129.26 | 146.55 | 177.20 | 283.20 |
| Profit before tax | 140.53 | 279.02 | 456.85 | 484.91 | 459.64 | 558.10 | 333.90 |
| Tax | 25.45 | 73.54 | 113.06 | 119.09 | 123.63 | 143.30 | 91.90 |
| Net profit | 119.18 | 201.22 | 332.69 | 336.32 | 310.15 | 384.50 | 241.40 |
| EPS (₹) | 2.98 | 5.03 | 8.38 | 8.41 | 7.75 | 9.61 | 6.03 |
| Dividend per share (₹) | 0.00 | 0.00 | — | — | — | — | — |
| ₹ crore | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|
| Total assets | 1,195.89 | 1,436.15 | 1,907.35 | 2,941.30 | 3,852.02 | 5,736.00 | 7,758.70 |
| Current assets | 219.83 | 451.20 | 393.40 | 477.64 | 547.44 | 697.30 | 937.40 |
| Cash & short-term investments | 45.73 | 284.44 | 190.07 | 134.24 | 131.98 | 101.70 | 70.50 |
| Inventory | 32.09 | 26.64 | 43.10 | 47.96 | 72.20 | 89.20 | 137.70 |
| Property, plant & equipment | 807.19 | 830.80 | 909.43 | 1,857.51 | 2,661.34 | 4,156.00 | 5,920.70 |
| Total liabilities | 597.77 | 572.42 | 520.04 | 1,271.76 | 2,023.66 | 3,598.20 | 5,511.30 |
| Current liabilities | 218.81 | 278.33 | 215.01 | 296.47 | 452.29 | 836.20 | 1,238.90 |
| Total debt | 368.73 | 316.37 | 256.53 | 678.17 | 1,355.33 | 2,556.70 | 4,252.90 |
| Total equity | 598.13 | 863.73 | 1,387.31 | 1,669.54 | 1,828.36 | 2,137.80 | 2,247.40 |
| ₹ crore | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|
| From operations | 201.50 | 355.97 | 324.03 | 563.23 | 521.09 | 582.20 | 510.80 |
| From investing | −124.71 | −354.18 | −411.52 | −615.60 | −752.56 | −1,116.20 | −1,451.70 |
| From financing | −44.34 | 9.82 | 61.00 | 88.34 | 216.76 | 543.10 | 940.30 |
| Capital expenditure | −51.98 | −94.43 | −170.32 | −574.53 | −647.34 | −1,008.90 | −1,427.90 |
| Dividends paid | — | — | — | — | — | — | — |
| Net change in cash | 32.45 | 11.62 | −26.49 | 35.98 | −14.72 | 9.10 | −0.60 |
What Analysts Say
12 analysts
Recommendations from 12 analysts who cover Krishna Institute of Medical Sciences Ltd.
Buy
average rating 1.92 on a 1–5 scale
Strong buyBuyHoldSellStrong sell
▲ 10 bullish (83.3%) · 0 hold (0.0%) · ▼ 2 bearish (16.7%)
Votes
Strong Buy
5 (42%)
Buy
5 (42%)
Hold
0 (0%)
Sell
2 (17%)
Strong Sell
0 (0%)
How the votes changed
| Rating | 3M ago | 2M ago | 1M ago | 1W ago | Now | 3-month change |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 5 | — |
| Buy | 3 | 4 | 4 | 5 | 5 | ▲ +2 |
| Hold | 1 | 1 | 1 | 0 | 0 | ▼ −1 |
| Sell | 1 | 1 | 1 | 2 | 2 | ▲ +1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | — |
Analyst ratings are opinions, not a guarantee of returns.
Krishna Institute of Medical Sciences Ltd vs Peers
Side by side with other healthcare facilities companies. The small bars compare each column.
| Company | Price | Change | Market cap | P/E | P/B | ROE (5 yr) | Net margin | Div. yield | Rating |
|---|---|---|---|---|---|---|---|---|---|
| Krishna Institute of Medical Sciences Ltd | ₹798.30 | ▲ +0.49% | ₹33,646 Cr | 159.64 | 14.21 | 18.71% | 4.61% | 0.00% | This stock |
| Apollo Hospitals Enterprise | ₹8,916.00 | ▼ −1.59% | ₹1,28,198 Cr | 64.93 | 13.39 | 18.12% | 7.76% | 0.23% | Bullish |
| Max Healthcare Institute | ₹1,046.20 | ▼ −0.60% | ₹1,01,828 Cr | 71.47 | 9.87 | 13.32% | 17.23% | 0.18% | Neutral |
| Fortis Healthcare | ₹880.00 | ▼ −1.23% | ₹66,436 Cr | 67.89 | 7.27 | 9.36% | 11.66% | 0.10% | Bearish |
| Aster DM Healthcare | ₹768.20 | ▲ +1.01% | ₹67,046 Cr | 102.55 | 9.26 | 7.13% | 9.20% | 0.49% | Neutral |
| Narayana Hrudayalaya | ₹1,878.85 | ▼ −2.22% | ₹38,317 Cr | 48.07 | 9.08 | 25.72% | 10.26% | 0.22% | Moderately Bearish |
Rating = the data provider's overall technical view of each peer. Company names link to their own pages.
Krishna Institute of Medical Sciences Ltd Key Metrics
Each ratio placed against a benchmark — the sector average, the company's own 5-year average, or a common rule of thumb.
Krishna Institute of Medical Sciences LtdBenchmarkComfortable → stretched
Valuation Is the price reasonable?
P/E (TTM)Price ÷ yearly earnings per share
159.64
▲ 425% above the sector average of 30.42
P/E, 12-month rangeLow 31.06 · high 159.64
100%
Today's P/E sits 100% of the way from its low to its high
P/BPrice ÷ book value per share
14.21
P/SPrice ÷ sales per share
7.96
P/CFPrice ÷ cash flow per share
63.84
Profitability Of every ₹100 of sales, how much is kept?
Gross marginKept after the cost of goods
79.36%
▲ above its 5-yr average of 53.21%
Operating marginKept after running costs
11.75%
▼ below its 5-yr average of 19.10%
Pre-tax marginKept before tax
6.57%
▼ below its 5-yr average of 17.26%
Net marginKept as profit
4.61%
▼ below its 5-yr average of 12.81%
Returns & efficiency How well does it use its money?
Return on equityProfit on shareholders' money
11.01%
▼ below its 5-yr average of 18.71%
Return on assetsProfit on everything it owns
3.59%
▼ below its 5-yr average of 8.94%
Return on investmentProfit on long-term capital
4.47%
▼ below its 5-yr average of 11.00%
Growth Is the business getting bigger?
Revenue — last 12 months
+30.9%
▲ growing (off the scale)
Revenue — 3 yr, a year
+21.1%
▲ growing
Revenue — 5 yr, a year
+24.0%
▲ growing
EPS — last 12 months
−45.7%
▼ shrinking (off the scale)
EPS — 3 yr, a year
−10.5%
▼ shrinking
EPS — 5 yr, a year
+3.7%
▲ growing
Book value — 5 yr, a year
+21.1%
▲ growing
Financial strength Can it pay its bills and debts?
Debt to equityBorrowings for every ₹1 of shareholders' money
1.89×
Current ratioShort-term assets for every ₹1 due within a year
0.76×
Quick ratioLike the current ratio, without inventory
0.65×
Interest coverOperating profit ÷ interest to pay
2.78×
Payout ratioShare of profit paid as dividend
0.00%
Per share What each share stands for
EPS (TTM)
₹5.10
Book value
₹56.17
Cash flow
₹13.12
Dividend
₹0.00
Revenue
₹105.24
The share price is 14.21× the book value behind each share.
Benchmarks: sector averages and 5-year averages come from the data provider; the debt and liquidity bands are common rules of thumb, not investment advice.
All 103 metrics from the data provider
Valuation
P/E excluding extraordinary items, most recent fiscal year132.28
Current Dividend Yield - Common Stock Primary Issue, LTM0.00
Price to Book - most recent fiscal year14.21
P/E Basic excluding extraordinary items - TTM159.64
P/E including extraordinary items - TTM156.40
P/E excluding extraordinary items low, trailing 12 months31.06
Price to Tangible Book - most fiscal year18.10
Price to sales - most recent fiscal year8.58
Price to Cash Flow per share - trailing 12 month63.84
P/E Normalized, most recent fiscal year129.22
P/E excluding extraordinary items high, trailing 12 months159.64
P/E excluding extraordinary items, most recent fiscal year quarter156.40
Price to sales - trailing 12 month7.96
Net Debt, LFY41,824.00
Per share
Cash Flow per share - trailing 12 month13.12
Cash Flow per share - most recent fiscal year13.13
EPS including extraordinary items - trailing 12 month5.10
EPS including extraordinary items - most recent fiscal year6.03
EBITD per share - trailing 12 month20.81
Revenue/share - trailing 12 month105.24
EPS excluding extraordinary items - trailing 12 month5.10
EPS Basic excluding extraordinary items - most recent fiscal year6.03
EPS Basic excluding extraordinary items - trailing 12 month5.10
Book value per share - most recent fiscal year56.17
Revenue/share - most recent fiscal year97.58
EPS Normalized - most recent fiscal year6.18
Book value (tangible) per share - most recent fiscal year46.28
Dividends per share - trailing 12 month0.00
EPS excluding extraordinary items - most recent fiscal year6.03
Cash per share - most recent fiscal year1.76
Margins
Operating margin - trailing 12 month11.75
Gross Margin - 5 year average53.21
Operating margin - 1st historical fiscal year13.15
Operating Margin - 5 year average19.10
Net Profit Margin % - 1st historical fiscal year6.20
Gross Margin - 1st historical fiscal year50.44
Net Profit Margin % - trailing 12 month4.61
Net Profit Margin - 5 year average12.81
Pretax Margin - 5 year average17.26
Pretax margin - 1st historical fiscal year8.55
Pretax margin - trailing 12 month6.57
Free Operating Cash Flow/Revenue, 5 Year Average−9.99
Gross Margin - trailing 12 month79.36
Growth
EPS Change %, TTM over TTM−45.74
Revenue growth rate, 5 year24.04
EPS growth rate, 5 year3.71
Revenue Change % - most recent quarter 1 year ago35.33
Growth rate% - EPS, 3 year−10.46
Revenue/share (5 yr growth)24.04
Tangible Book Value, Total Equity, 5 Year CAGR19.68
Earnings Before Interest, Taxes, Depreciation & Amortization, 5 Year Interim CAGR11.65
Capital Spending growth rate, 5 year72.16
Revenue Change %, TTM over TTM30.89
Growth rate% - Revenue, 3 year21.12
Book value per share growth rate, 5 year21.08
EPS Change % - most recent quarter 1 year ago−47.07
Net Profit Margin growth rate, 5 year−16.70
Earnings Before Interest, Taxes, Depreciation & Amortization, 5 Year CAGR16.63
Total Debt, 5 Year CAGR68.15
Financial strength
Net Interest coverage - most recent fiscal year2.78
Free Cash Flow - most recent fiscal year−9,171.00
LT debt/equity - most recent fiscal year1.62
Quick ratio - most recent fiscal year0.65
Payout ratio - trailing 12 month0.00
Current ratio - most recent fiscal year0.76
Total debt/total equity - most recent fiscal year1.89
Net Interest coverage - trailing 12 month1.98
Payout ratio - most recent fiscal year0.00
Returns & efficiency
Return on average equity - 5 year average18.71
Net Income/employee - trailing 12 month3,15,840.80
Revenue/employee - most recent fiscal year68,38,778.00
Return on investment - most recent fiscal year4.47
Return on average assets - most recent fiscal year3.59
Receivables turnover - most recent fiscal year7.50
Inventory turnover - most recent fiscal year17.06
Revenue/employee - trailing 12 month68,44,029.00
Return on average assets - 5 year average8.94
Net Income/employee - most recent fiscal year4,23,855.00
Asset turnover - most recent fiscal year0.58
Return on average equity - most recent fiscal year11.01
Return on investment - 5 year average11.00
Price & volume
Market Cap33,646.01
52 week Low Date27 Jan 2026
Price - 1 Day % Change1.04
Relative (S&P500) price percent change - 13 week3.00
Avg trading volume last 10 days0.49
Price - 13 week price percent change0.11
Price - 52 week price percent change8.37
Avg Trading Volume Last 3 months11.79
Price - 5 Day % Change4.10
Price % Change Month To Date5.63
Relative (S&P500) price percent change - 04 week9.28
52 week High Date6 Jul 2026
Price - 26 week price percent change22.89
PDATE23 Sep 2026
Price - YTD price percent change31.13
Relative (S&P500) price percent change - 52 week18.91
NPRICE798.05
Relative (S&P500) price percent change - 26 week23.62
52 week Low575.80
52 week High858.00
Beta0.77
Relative (S&P500) price percent change - Year to Date49.34
Dividends & Corporate Events
Payouts to shareholders, splits and bonus issues, and company meetings — newest first.
- Dividend yield0.00%
- Payout ratio0.00%
No dividends on record.
Corporate calendar
- MeetingAnnual General Meeting
- BoardQuarterly Results
- MeetingExtraordinary General Meeting
- BoardOthers
- BoardAudited Results
- MeetingPostal Ballot
- BoardRights Issue & Others
- BoardQuarterly Results
Show 7 older events
- MeetingPostal Ballot
- BoardQuarterly Results
- MeetingAnnual General Meeting
- BoardQuarterly Results
- BoardAudited Results
- MeetingPostal Ballot
- SplitStock split — face value ₹10 → ₹2
About Krishna Institute of Medical Sciences Ltd
Healthcare Facilities
Krishna Institute of Medical Sciences Ltd is an India-based company, which is primarily engaged in the business of rendering medical and healthcare services. The Company's departments include accident, Alzheimer center, andrology and Male infertility center, pediatric obesity, pediatric oncology and hematology center, pediatric orthopedics and rheumatology, pediatric renal centre, pediatric surgical centre, female urology centre, fertility centre, gastrointestinal oncology, general surgery, heart wellness center, hepatobiliary surgery center, and others. Its medical technologies include 4-Arm HD da Vinci Robotic Surgical System, O-Arm Scanner, Novalis Tx Linear Accelerator, 3 Tesla MRI, 4D Scan for pregnancy, EBUS, Spy Glass, Mako Robotic for Knee Replacement, Impella, and others. The Company's institutes include the Institute of Cardiac Sciences, Institute of Dental Science, Institute of Gastroenterology & Hepatology, Institute of Heart & Lung Transplantation, among others.
Key people
- Bhaskara Rao BollineniExecutive Chairman of the Board, Managing Director
- Abhinay BollineniChief Executive Officer, Executive Director
- Sachin Ashok SalviChief Financial Officer
- Nagajayanthi Juttur Raghavendra DasCompany Secretary and Compliance Officer
- Adwik BollineniExecutive Director
- Anitha DandamudiWhole-time Director
Company facts
- NSE symbolKIMS
- BSE code543308
- ISININE967H01025
- IndustryHealthcare Facilities
- IndexNIFTY 500
- Market cap₹33,646 Cr
- Revenue (FY26)₹3,905 Cr
- Net profit (FY26)₹241 Cr
In the News
Recent headlines about Krishna Institute of Medical Sciences Ltd — they open on Mint in a new tab.
- Stock market today: Gift Nifty hints muted opening; US-Iran war, gold to crude oil prices — eight stocks to buy or sell
Indian stock markets are expected to open flat-to-negative on June 9, 2026, with Gift Nifty at 23,121.5. This follows a significant drop on Monday due to geopolitical tensions and rising crude prices, amid cautious global sentiment and increasing market volatility.
9 Jun 2026 · 5 min read · Mint ↗
Stock data comes from the exchange feed via our data provider and may be delayed. It is for information only and is not a recommendation to buy or sell. See all stocks →
Frequently Asked Questions
Krishna Institute of Medical Sciences Ltd (NSE: KIMS) last traded at ₹798.30 on the NSE, up 0.49% (₹3.89) on the day, as of 24 Sep 2026, 9:51 AM. On the BSE it was ₹802.25. The day's range was ₹796.50 – ₹810.40.
Krishna Institute of Medical Sciences Ltd's 52-week high is ₹858.15 (6 Jul 2026) and its 52-week low is ₹575.55 (27 Jan 2026). At ₹798.30 the share is 7.0% below its high and 38.7% above its low.
Krishna Institute of Medical Sciences Ltd's market capitalisation is ₹33,646 Cr (₹33,646 Cr). It is part of the NIFTY 500 index.
Krishna Institute of Medical Sciences Ltd's P/E ratio (trailing 12 months) is 159.64. The sector average is 30.42, so investors pay 425% more for each rupee of its earnings than for the average company in its sector. Its earnings per share (TTM) are ₹5.10.
Krishna Institute of Medical Sciences Ltd shares are up 8.37% over the last year, up 31.13% so far this year, up 22.89% over 6 months, up 0.11% over 3 months. Over the last year the stock did 18.91% better than the market.
In FY26 (year to Mar 2026), Krishna Institute of Medical Sciences Ltd reported revenue of ₹3,905 Cr (up 28.65% on the year before) and a net profit of ₹241 Cr. Earnings per share were ₹6.03.
There is no dividend on record for Krishna Institute of Medical Sciences Ltd in the data shown on this page.
Of 12 analysts covering Krishna Institute of Medical Sciences Ltd, 10 are bullish (5 strong buy, 5 buy), 0 say hold and 2 are bearish. The consensus is Buy (average rating 1.92 on a scale where 1 is Strong Buy and 5 is Strong Sell). Analyst views are opinions, not a guarantee.
As of Jun 2026: Promoter 32.50%, FII 14.75%, MF 28.52%, Other 24.23%. Promoter holding fell by 1.61 percentage points from Mar 2026.
Krishna Institute of Medical Sciences Ltd's listed peers in Healthcare Facilities include Apollo Hospitals Enterprise, Max Healthcare Institute, Fortis Healthcare, Aster DM Healthcare, Narayana Hrudayalaya. By market capitalisation it ranks #6 of 6 in this group.